Division of Endocrinology and Metabolism, Diabetes Center, Department of Medicine, Jichi Medical University, Shimotsuke 329-0498, Japan.
Acta Diabetol. 2012 Dec;49 Suppl 1:S195-204. doi: 10.1007/s00592-012-0417-y. Epub 2012 Jul 27.
Aim of this study was to formulate an index for glucose effectiveness (Sg), SgIo, based on 3-point (0, 30 and 120 min) 75 g oral glucose tolerance test (OGTT). The equation for SgI(O) was developed in the Chikuma cohort (n = 502). Firstly, post-loading plasma glucose without insulin action and Sg (PPG-without insulin and Sg) was calculated as follows: fasting plasma glucose (mg/dl) + [0.75 × 75,000]/[0.19 × BW(kg) × 10]. Secondly, 'PPG-without insulin/with Sg' was obtained from inverse correlation between log(10)DI(O) and 2-h post-glucose plasma glucose at OGTT (2hPG) in each glucose tolerance category: DI(O) denotes oral disposition index, a product of the Matsuda Index and δIRI(0-30)/δPG(0-30). Thirdly, expected 2hPG (2hPG(E)) of a given subject was obtained from the regression, and the ratio of 2hPG to 2hPG(E) (2hPG/2hPG(E)) was determined as an adjustment factor. Lastly, SgI(O) ([mg/dl]/min) was calculated as [PPG-without insulin and Sg]-[PPG-without insulin / with Sg] x [(2hPG) / 2hPG(E)]. SgI(O) was validated against Sg obtained by frequently sampled intravenous glucose tolerance test in the Jichi cohort (n = 205). Also, the accuracy of prediction of Sg by SgIo was tested by the Bland-Altman plot. SgI(O) was 3.61 ± 0.73, 3.17 ± 0.74 and 2.15 ± 0.60 in subjects with normal glucose tolerance (NGT), non-diabetic hyperglycemia and diabetes, respectively, in the Chikuma cohort. In the Jichi cohort, SgI(O) was significantly correlated with Sg in the entire group (r = 0.322, P < 0.001) and in subjects with NGT (r = 0.286, P < 0.001), and SgIo accurately predicted Sg. In conclusion, SgI(O) could be a simple, quantitative index for Sg.
本研究旨在基于 75g 口服葡萄糖耐量试验(OGTT)的 3 点(0、30 和 120 分钟)制定葡萄糖效应(Sg)指数 SgIo。Chikuma 队列(n=502)中开发了 SgI(O)方程。首先,计算无胰岛素作用的负荷后血浆葡萄糖和 Sg(PPG-无胰岛素和 Sg)如下:空腹血浆葡萄糖(mg/dl)+[0.75×75000]/[0.19×BW(kg)×10]。其次,从每个糖耐量类别中 OGTT 2 小时后葡萄糖血浆葡萄糖与 log(10)DI(O)的负相关关系中获得“PPG-无胰岛素/有 Sg”:DI(O)表示口服处置指数,是 Matsuda 指数与 δIRI(0-30)/δPG(0-30)的乘积。第三,从回归中获得给定受试者的预期 2hPG(2hPG(E)),并确定 2hPG 与 2hPG(E)的比值(2hPG/2hPG(E))作为调整因子。最后,计算 SgI(O)[mg/dl]/min 为[PPG-无胰岛素和 Sg]-[PPG-无胰岛素/有 Sg]×[(2hPG)/2hPG(E)]。在 Jichi 队列(n=205)中,通过频繁采样静脉葡萄糖耐量试验验证了 SgI(O),并通过 Bland-Altman 图测试了 SgIo 预测 Sg 的准确性。在 Chikuma 队列中,正常糖耐量(NGT)、非糖尿病性高血糖和糖尿病患者的 SgI(O)分别为 3.61±0.73、3.17±0.74 和 2.15±0.60。在 Jichi 队列中,SgI(O)在整个组(r=0.322,P<0.001)和 NGT 受试者(r=0.286,P<0.001)中与 Sg 显著相关,并且 SgIo 准确预测了 Sg。总之,SgI(O)可能是 Sg 的简单定量指标。